0001171843-21-003571.txt : 20210517 0001171843-21-003571.hdr.sgml : 20210517 20210517134244 ACCESSION NUMBER: 0001171843-21-003571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210517 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POWERS JOHNNY D CENTRAL INDEX KEY: 0001134545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38298 FILM NUMBER: 21929288 MAIL ADDRESS: STREET 1: C/O ZOMEDICA CORP. STREET 2: 100 PHOENIX DRIVE, SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48018 FORMER NAME: FORMER CONFORMED NAME: POWERS JOHNNY DATE OF NAME CHANGE: 20010212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 369-2555 MAIL ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: Zomedica Pharmaceuticals Corp. DATE OF NAME CHANGE: 20160908 4 1 ownership.xml X0306 4 2021-05-17 0 0001684144 Zomedica Corp. ZOM 0001134545 POWERS JOHNNY D C/O ZOMEDICA CORP. 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR MI 48108 1 0 0 0 Common Stock, without par value 2021-05-17 4 M 0 125000 .26 A 1375000 D Common Stock, without par value 2021-05-17 4 S 0 125000 0.7759 D 1250000 D Stock option (right to buy) 0.26 2021-05-17 4 M 0 125000 0 D 2019-08-16 2021-08-16 Common Stock, without par value 125000 125000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.763 to $0.788 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. /s/ John Hogoboom, as attorney-in-fact 2021-05-17